Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial
- PMID: 24973862
- DOI: 10.1016/j.clnu.2014.06.005
Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial
Abstract
Background & aims: We are aware of no study that examined the effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes (GDM). This study was designed to assess the effects of omega-3 fatty acid supplementation on insulin concentrations and lipid profiles among pregnant women with GDM.
Methods: This randomized, double-blind, placebo-controlled clinical trial was performed among 56 women with GDM. Subjects were randomly assigned to receive either 1000 mg omega-3 fatty acid supplements containing 180 mg eicosapentaenoic acid and 120 mg docosahexanoic acid (n = 28) or placebo (n = 28) for 6 weeks. Fasting blood samples were taken at study baseline and after 6 weeks of intervention to quantify biochemical variables.
Results: Although omega-3 fatty acid supplementation did not led to a significant change in serum insulin levels and HOMA-IR in omega-3 fatty acid group, we found a significant difference in changes in serum insulin levels (change from baseline: -1.5 ± 7.5 vs. +3.5 ± 8.5 μIU/mL, P = 0.02) and HOMA-IR (-0.4 ± 2.1 vs. +1.1 ± 2.4, P = 0.02) comparing the two groups. Furthermore, a significant reduction in serum high sensitivity C-reactive protein (hs-CRP) levels was seen after omega-3 fatty acid supplementation compared with placebo (-236.3 ± 1541.9 vs. 898.6 ± 2292.7 ng/mL, P = 0.03). Omega-3 fatty acid supplementation did not influence fasting plasma glucose, homeostatic model assessment-Beta cell function (HOMA-B), quantitative insulin sensitivity check index (QUICKI) and lipid profiles.
Conclusions: Omega-3 fatty acid supplementation in GDM women had beneficial effects on insulin resistance, however, it did not affect plasma glucose, HOMA-B, QUICKI and lipid profiles. Clinical registration number: www.irct.ir as IRCT201312265623N16.
Keywords: Gestational diabetes; Omega-3 fatty acid; Pregnant women; Supplementation.
Copyright © 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Similar articles
-
A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes.J Clin Lipidol. 2016 Mar-Apr;10(2):386-93. doi: 10.1016/j.jacl.2015.12.017. Epub 2015 Dec 29. J Clin Lipidol. 2016. PMID: 27055970 Clinical Trial.
-
Effects of selenium supplementation on glucose homeostasis, inflammation, and oxidative stress in gestational diabetes: Randomized, double-blind, placebo-controlled trial.Nutrition. 2015 Oct;31(10):1235-42. doi: 10.1016/j.nut.2015.04.014. Epub 2015 May 14. Nutrition. 2015. PMID: 26250486 Clinical Trial.
-
Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.Clin Nutr. 2017 Feb;36(1):79-84. doi: 10.1016/j.clnu.2015.11.003. Epub 2015 Nov 11. Clin Nutr. 2017. PMID: 26611718 Clinical Trial.
-
The impact of omega-3 fatty acid supplementation on glycemic control in patients with gestational diabetes: a systematic review and meta-analysis of randomized controlled studies.J Matern Fetal Neonatal Med. 2020 May;33(10):1767-1773. doi: 10.1080/14767058.2018.1526916. Epub 2018 Oct 29. J Matern Fetal Neonatal Med. 2020. PMID: 30231792
-
Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.J Diabetes Complications. 2023 Apr;37(4):108451. doi: 10.1016/j.jdiacomp.2023.108451. Epub 2023 Mar 7. J Diabetes Complications. 2023. PMID: 36913875 Review.
Cited by
-
Development of omega-3 rich eggs through dietary flaxseed and bio-evaluation in metabolic syndrome.Food Sci Nutr. 2020 Apr 30;8(6):2619-2626. doi: 10.1002/fsn3.1522. eCollection 2020 Jun. Food Sci Nutr. 2020. PMID: 32566179 Free PMC article.
-
Omega-3 fatty acid addition during pregnancy.Cochrane Database Syst Rev. 2018 Nov 15;11(11):CD003402. doi: 10.1002/14651858.CD003402.pub3. Cochrane Database Syst Rev. 2018. PMID: 30480773 Free PMC article.
-
Nutrition Therapy in Managing Pregnant Women With Gestational Diabetes Mellitus: A Literature Review.J Family Reprod Health. 2018 Jun;12(2):57-72. J Family Reprod Health. 2018. PMID: 30820209 Free PMC article. Review.
-
The Effectiveness of Perinatal Omega-3 Supplements in Neurodevelopment and Physical Growth of 9- and 12-month-old Infants: A Follow-up of a Clinical Trial.Curr Pediatr Rev. 2024;21(1):91-99. doi: 10.2174/0115733963273591231214112617. Curr Pediatr Rev. 2024. PMID: 38173204 Clinical Trial.
-
Maternal Omega-3 Nutrition, Placental Transfer and Fetal Brain Development in Gestational Diabetes and Preeclampsia.Nutrients. 2019 May 18;11(5):1107. doi: 10.3390/nu11051107. Nutrients. 2019. PMID: 31109059 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous